查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829804

2025年全球结构性心臟器材市场报告

Structural Heart Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，结构性心臟器材市场规模强劲成长，从2024年的104.1亿美元增加至2025年的113.7亿美元，复合年增长率达9.3%。这段时期的成长归因于向微创手术技术的转变、对微创结构性心臟器材的需求、医疗专业人员持续的培训和教育计画、不断上涨的医疗成本以及患者对非手术或微创治疗方案的日益偏好。

预计未来几年结构性心臟器材市场规模将强劲成长，到2029年将达到161亿美元，年复合成长率（CAGR）为9.1%。预测期内的成长归因于人口老化加剧、心臟健康意识增强、筛检计画的实施、结构性心臟手术的优惠报销政策以及新型结构性心臟器械的及时监管核准。预测期内的主要趋势包括经导管瓣膜置换术的普及率不断提高、采用尖端材料的创新器械的持续开发、对个性化治疗方法的日益重视、混合手术的普及率不断提高以及远端监控和远端医疗解决方案的整合。

结构性心臟器械是专门用于治疗各种心臟结构缺陷和异常的医疗植入和工具。它们透过修復或替换受损的心臟结构（例如瓣膜和隔膜），恢復正常的心臟功能并改善患者的预后。

结构性心臟装置的主要类型包括心臟瓣膜装置、环状成形术环、封堵器和输送系统。心臟瓣膜装置是用于修復或更换受损心臟瓣膜并确保心臟血流正常的医疗器材。这些手术包括置换手术、针对心房中膈缺损症、卵圆孔未闭合、室间隔缺损和主动脉瓣狭窄等适应症的修復手术，以及针对小儿科和成人等年龄层的手术。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供结构性心臟器械市场统计数据，例如全球市场规模、区域份额、竞争对手的市场份额、详细的结构性心臟器械市场细分、市场趋势和商机，以及您在结构性心臟器械行业取得成功所需的数据。本结构性心臟器械市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年的预测成长率为 9.1%，比我们先前对该市场的预测略有下降 0.5%。这一下降主要是由于美国与其他国家之间的关税影响。美国可能会直接感受到这种影响，因为环状成形术环和腱索修復系统等关键零件的供应链中断，这些零件来自义大利、巴西和马来西亚等主要地区，可能导致心臟植入短缺和价格上涨。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响可能更为广泛。

心血管疾病的日益普及预计将在未来几年推动结构性心臟器械市场的成长。心血管疾病 (CVD) 包括影响心臟和血管的各种疾病，例如冠状动脉疾病、心臟病发作和中风。由于久坐不动的生活方式、不良饮食、肥胖、吸烟和人口老化等因素，包括心臟病和中风在内的心血管疾病的全球盛行率正在稳步上升。结构性心臟器械用于治疗这些疾病，包括修復或更换受损的心臟瓣膜、纠正结构缺陷以及改善心臟功能和患者预后。例如，2024 年 9 月，英国心血管研究慈善机构英国心臟基金会报告称，英国约有 760 万人患有心臟和循环系统疾病，其中 400 万男性和 360 万女性患有这些疾病。这些疾病约占英国所有死亡人数的27%，每年造成超过17万人死亡，相当于每天约480人，每三分钟就有一人死亡。因此，心血管疾病盛行率的不断上升正在推动心臟结构性器械市场的扩张。

结构性心臟器械市场的主要企业正致力于开发微创治疗技术和器械，以改善患者预后、缩短復健时间并拓展结构性心臟病的治疗方案。一个显着的例子是自膨式经导管主动脉瓣植入 (TAVI) 系统，该系统旨在将替换瓣膜在原生主动脉瓣结构内释放并固定，无需球囊扩张。例如，2022 年 12 月，雅培实验室在印度推出了最新一代经导管主动脉瓣植入 (TAVI) 系统 N​​avitor。 Navitor 专为手术风险高或极高的重度主动脉瓣狭窄患者量身定制，并采用了先进技术，包括独特的瓣膜渗漏预防设计。这项创新扩展了雅培的结构性心臟经导管产品组合，为医生和患者提供了心臟病的微创治疗选择。 Navitor 是唯一采用环内瓣叶和大型框架单元的自膨式 TAVI 系统，有助于改善冠状动脉通路，为未来冠状动脉疾病 (CAD) 的介入治疗提供便利。此外，这种新颖的设计还能改善血流动力学并优化血流。

2022年2月，Genesis Meditech Group收购了JC Medical (JCM)，收购金额未揭露。这项策略性措施使Genesis能够扩展产品系列，其中包括J-Valve，这是一种微创经导管主动脉瓣置换术(TAVR)装置，专为主动脉瓣逆流和狭窄患者设计。 JC Medical (JCM)是一家总部位于美国的公司，专门生产结构性心臟器械。

结构性心臟器械市场包括瓣週漏封堵装置、血管内支架和经皮二尖瓣置换术的销售。该市场的价值指的是“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球结构性心臟设备：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球结构性心臟器械市场：成长率分析
  • 全球结构性心臟器材市场表现：规模与成长，2019-2024
  • 全球结构性心臟器材市场预测：规模与成长，2024-2029，2034
  • 全球结构性心臟设备：总目标市场（TAM）

第六章 市场细分

  • 全球结构性心臟器材市场类型、表现及预测（2019-2024、2024-2029、2034）
  • 心臟瓣膜装置
  • 环状成形术环
  • 封堵器
  • 输送系统
  • 全球结构性心臟器械市场（按手术方式、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 更换程序
  • 修復程式
  • 全球结构性心臟器材市场（依适应症、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 心房中膈缺损症
  • 卵圆孔未闭合未闭
  • 室间隔缺损
  • 主动脉瓣狭窄
  • 其他的
  • 全球结构性心臟器材市场（依年龄层、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 孩子们
  • 成人
  • 全球结构性心臟器材市场：心臟瓣膜器械细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 经导管心臟瓣膜
  • 外科心臟瓣膜
  • 环状成形术环
  • 全球结构性心臟器材市场：环状成形术成形术环细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 二尖瓣环状成形术环
  • 主动脉环状成形术环
  • 全球结构性心臟器材市场：封堵器细分市场、类型、性能及预测（2019-2024、2024-2029、2034）
  • 心房间隔缺损 (ASD) 封堵器
  • 卵圆孔未闭合（PFO）封堵器
  • 全球结构性心臟器材市场：输送系统细分、类型、性能及预测（2019-2024、2024-2029、2034）
  • 球囊输送系统
  • 基于导管的输送系统

第七章 区域和国家分析

  • 全球结构性心臟器材市场：2019-2024 年、2024-2029 年及 2034 年区域表现与预测
  • 全球结构性心臟器材市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 结构性心臟器材市场：竞争格局
  • 结构性心臟器械市场：公司简介
    • Abbott Laboratories
    • Medtronic Plc
    • Boston Scientific Corporation
    • Terumo Corporation
    • Edwards Lifesciences Corporation

第31章：其他领先和创新企业

  • WL Gore & Associates Inc.
  • Bracco Group
  • LivaNova PLC
  • Meril Life Sciences Pvt. Ltd.
  • CryoLife Inc.
  • Braile Biomedica
  • TTK Healthcare Limited
  • Direct Flow Medical Inc.
  • JenaValve Technology Inc.
  • Micro Interventional Devices Inc.
  • CardioKinetix Inc.
  • Xeltis AG
  • Ancora Heart Inc.
  • JOMDD Inc.
  • Valcare Medical

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年结构性心臟器材市场：提供新机会的国家
  • 2029年结构性心臟器材市场：细分市场带来新机会
  • 2029年结构性心臟器材市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r31325u

Structural heart devices are specialized medical implants or tools tailored for treating various structural defects or abnormalities affecting the heart. They are utilized to repair or replace damaged heart structures, such as valves or septa, thereby restoring normal heart functions and enhancing patient outcomes.

The primary types of structural heart devices include heart valve devices, annuloplasty rings, occluders, and delivery systems. Heart valve devices are medical tools crafted to repair or replace damaged heart valves, ensuring proper blood flow through the heart. These procedures encompass replacement procedures, repair procedures for indications such as atrial septal defect, patent foramen ovale, ventricular septal defect, aortic valve stenosis, and others, catering to age group categories including pediatrics and adults.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The structural heart devices market research report is one of a series of new reports from The Business Research Company that provides structural heart devices market statistics, including structural heart devices industry global market size, regional shares, competitors with a structural heart devices market share, detailed structural heart devices market segments, market trends and opportunities, and any further data you may need to thrive in the structural heart devices industry. This structural heart devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The structural heart devices market size has grown strongly in recent years. It will grow from $10.41 billion in 2024 to $11.37 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to the shift towards less invasive surgical techniques, the demand for minimally invasive structural heart devices, ongoing training and education programs for healthcare professionals, rising healthcare expenditure, growing patient preference for non-surgical or minimally invasive treatment options.

The structural heart devices market size is expected to see strong growth in the next few years. It will grow to $16.1 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to the increasing aging population, growing awareness about heart health, the implementation of screening programs, favorable reimbursement policies for structural heart procedures, timely regulatory approvals for new structural heart devices. Major trends in the forecast period include increasing adoption of transcatheter valve replacement, ongoing development of innovative devices with advanced materials, growing emphasis on personalized treatment approaches, increasing adoption of hybrid procedures, integration of remote monitoring and telehealth solutions.

The forecast of 9.1% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for critical components like annuloplasty rings and chordal repair systems, sourced from key regions such as Italy, Brazil, and Malaysia, which could lead to inventory shortages and higher prices for cardiac implants.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the structural heart device market in the coming years. Cardiovascular diseases (CVDs) encompass a range of conditions that affect the heart and blood vessels, such as coronary artery disease, heart attacks, and strokes. The global incidence of cardiovascular diseases, including heart disease and stroke, has been steadily rising, driven by factors such as sedentary lifestyles, poor diet, obesity, smoking, and aging populations. Structural heart devices are used to treat these diseases by repairing or replacing damaged heart valves, correcting structural defects, and enhancing heart function and patient outcomes. For example, in September 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with 4 million males and 3.6 million females living with these conditions. These diseases account for about 27% of all deaths in the UK, resulting in over 170,000 deaths annually, or roughly 480 deaths per day, which equates to one death every three minutes. As a result, the growing prevalence of cardiovascular diseases is fueling the expansion of the structural heart device market.

Leading companies in the structural heart devices market are focusing on developing minimally invasive treatment techniques and devices to improve patient outcomes, shorten recovery periods, and broaden treatment options for structural heart conditions. A notable example is the self-expanding transcatheter aortic valve implantation (TAVI) system, designed to deploy and secure the replacement valve within the native aortic valve anatomy without the need for balloon inflation. For instance, in December 2022, Abbott Laboratories introduced Navitor, the latest-generation transcatheter aortic valve implantation (TAVI) system, in India. Navitor is specifically tailored for individuals with severe aortic stenosis at high or extreme surgical risk and incorporates advancements such as a unique design to prevent valve leakage. This innovation expands Abbott's structural heart transcatheter portfolio, offering both physicians and patients minimally invasive treatment alternatives for heart diseases. Navitor stands out as the sole self-expanding TAVI system with intra-annular leaflets and large frame cells, facilitating improved access to coronary arteries for potential future interventions in coronary artery disease (CAD). Additionally, this new design enhances hemodynamics, optimizing blood flow.

In February 2022, Genesis MedTech Group completed the acquisition of JC Medical (JCM) for an undisclosed sum. This strategic move allows Genesis to augment its product portfolio by including J-Valve, a minimally invasive transcatheter aortic valve replacement (TAVR) device designed for both aortic regurgitation and stenosis patients. JC Medical (JCM) is a US-based company specializing in the manufacture of structural heart devices.

Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Bracco Group, LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomedica, TTK Healthcare Limited, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH, Navilyst Medical Inc.

North America was the largest region in the structural heart devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the structural heart devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The structural heart devices market consists of sales of paravalvular leak closure devices, endovascular stents, and percutaneous mitral valve replacement. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Structural Heart Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on structural heart devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for structural heart devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The structural heart devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Heart Valve Devices; Annuloplasty Rings; Occluders; Delivery Systems
  • 2) By Procedure: Replacement Procedures; Repair Procedures
  • 3) By Indication: Atrial Septal Defect; Patent Foramen Ovale; Ventricular Septal Defect; Aortic Valve Stenosis; Other Indications
  • 4) By Age Group: Pediatric; Adults
  • Subsegments:
  • 1) By Heart Valve Devices: Transcatheter Heart Valves; Surgical Heart Valves; Annuloplasty Rings
  • 2) By Annuloplasty Rings: Mitral Annuloplasty Rings; Aortic Annuloplasty Rings
  • 3) By Occluders: Atrial Septal Defect (Asd) Occluders; Patent Foramen Ovale (Pfo) Occluders
  • 4) By Delivery Systems: Balloon Delivery Systems; Catheter-Based Delivery Systems
  • Companies Mentioned: Abbott Laboratories; Medtronic Plc; Boston Scientific Corporation; Terumo Corporation; Edwards Lifesciences Corporation; W. L. Gore & Associates Inc.; Bracco Group; LivaNova PLC; Meril Life Sciences Pvt. Ltd.; CryoLife Inc.; Braile Biomedica; TTK Healthcare Limited; Direct Flow Medical Inc.; JenaValve Technology Inc.; Micro Interventional Devices Inc.; CardioKinetix Inc.; Xeltis AG; Ancora Heart Inc.; JOMDD Inc.; Valcare Medical; BioStable Science & Engineering Inc.; Comed B.V.; Transcatheter Technologies GmbH; Navilyst Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Structural Heart Devices Market Characteristics

3. Structural Heart Devices Market Trends And Strategies

4. Structural Heart Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Structural Heart Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Structural Heart Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Structural Heart Devices Market Growth Rate Analysis
  • 5.4. Global Structural Heart Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Structural Heart Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Structural Heart Devices Total Addressable Market (TAM)

6. Structural Heart Devices Market Segmentation

  • 6.1. Global Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Heart Valve Devices
  • Annuloplasty Rings
  • Occluders
  • Delivery Systems
  • 6.2. Global Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Replacement Procedures
  • Repair Procedures
  • 6.3. Global Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Atrial Septal Defect
  • Patent Foramen Ovale
  • Ventricular Septal Defect
  • Aortic Valve Stenosis
  • Other Indications
  • 6.4. Global Structural Heart Devices Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pediatric
  • Adults
  • 6.5. Global Structural Heart Devices Market, Sub-Segmentation Of Heart Valve Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcatheter Heart Valves
  • Surgical Heart Valves
  • Annuloplasty Rings
  • 6.6. Global Structural Heart Devices Market, Sub-Segmentation Of Annuloplasty Rings, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mitral Annuloplasty Rings
  • Aortic Annuloplasty Rings
  • 6.7. Global Structural Heart Devices Market, Sub-Segmentation Of Occluders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Atrial Septal Defect (Asd) Occluders
  • Patent Foramen Ovale (Pfo) Occluders
  • 6.8. Global Structural Heart Devices Market, Sub-Segmentation Of Delivery Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloon Delivery Systems
  • Catheter-Based Delivery Systems

7. Structural Heart Devices Market Regional And Country Analysis

  • 7.1. Global Structural Heart Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Structural Heart Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Structural Heart Devices Market

  • 8.1. Asia-Pacific Structural Heart Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Structural Heart Devices Market

  • 9.1. China Structural Heart Devices Market Overview
  • 9.2. China Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Structural Heart Devices Market

  • 10.1. India Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Structural Heart Devices Market

  • 11.1. Japan Structural Heart Devices Market Overview
  • 11.2. Japan Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Structural Heart Devices Market

  • 12.1. Australia Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Structural Heart Devices Market

  • 13.1. Indonesia Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Structural Heart Devices Market

  • 14.1. South Korea Structural Heart Devices Market Overview
  • 14.2. South Korea Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Structural Heart Devices Market

  • 15.1. Western Europe Structural Heart Devices Market Overview
  • 15.2. Western Europe Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Structural Heart Devices Market

  • 16.1. UK Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Structural Heart Devices Market

  • 17.1. Germany Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Structural Heart Devices Market

  • 18.1. France Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Structural Heart Devices Market

  • 19.1. Italy Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Structural Heart Devices Market

  • 20.1. Spain Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Structural Heart Devices Market

  • 21.1. Eastern Europe Structural Heart Devices Market Overview
  • 21.2. Eastern Europe Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Structural Heart Devices Market

  • 22.1. Russia Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Structural Heart Devices Market

  • 23.1. North America Structural Heart Devices Market Overview
  • 23.2. North America Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Structural Heart Devices Market

  • 24.1. USA Structural Heart Devices Market Overview
  • 24.2. USA Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Structural Heart Devices Market

  • 25.1. Canada Structural Heart Devices Market Overview
  • 25.2. Canada Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Structural Heart Devices Market

  • 26.1. South America Structural Heart Devices Market Overview
  • 26.2. South America Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Structural Heart Devices Market

  • 27.1. Brazil Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Structural Heart Devices Market

  • 28.1. Middle East Structural Heart Devices Market Overview
  • 28.2. Middle East Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Structural Heart Devices Market

  • 29.1. Africa Structural Heart Devices Market Overview
  • 29.2. Africa Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Structural Heart Devices Market Competitive Landscape And Company Profiles

  • 30.1. Structural Heart Devices Market Competitive Landscape
  • 30.2. Structural Heart Devices Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Structural Heart Devices Market Other Major And Innovative Companies

  • 31.1. W. L. Gore & Associates Inc.
  • 31.2. Bracco Group
  • 31.3. LivaNova PLC
  • 31.4. Meril Life Sciences Pvt. Ltd.
  • 31.5. CryoLife Inc.
  • 31.6. Braile Biomedica
  • 31.7. TTK Healthcare Limited
  • 31.8. Direct Flow Medical Inc.
  • 31.9. JenaValve Technology Inc.
  • 31.10. Micro Interventional Devices Inc.
  • 31.11. CardioKinetix Inc.
  • 31.12. Xeltis AG
  • 31.13. Ancora Heart Inc.
  • 31.14. JOMDD Inc.
  • 31.15. Valcare Medical

32. Global Structural Heart Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Structural Heart Devices Market

34. Recent Developments In The Structural Heart Devices Market

35. Structural Heart Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Structural Heart Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Structural Heart Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Structural Heart Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer